The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers

American Journal of Pathology

Volumn 151, Issue 6, 1997, Pages 1541-1547

  Xiao, Guang Hui ^a   Jin, Fang ^a   Klein Szanto, Andres J P ^a   Goodrow, Tamra L ^a   Linehan, Marston W ^b   Yeung, Raymond S ^a,c  

^a FOX CHASE CANCER CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HISTIDINE;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 3P; CHROMOSOME DELETION; CONTROLLED STUDY; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY TUBULE EPITHELIUM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; CARCINOMA, RENAL CELL; CELL LINE, TRANSFORMED; CYTOPLASM; DOWN-REGULATION; EPITHELIUM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HELA CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; KIDNEY TUBULES; NEOPLASM PROTEINS; PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030700225     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site, and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-587
2. Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K: Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 1997, 57:504-512
3. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue J, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K, Croce CM: The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996, 85:17-26
4. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM: The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 1996, 56:3173-3179
5. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, Croce CM: FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 1996, 93:9770-9775
6. Mao L, Fan YH, Lotan R, Hong WK: Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 1996, 56:5128-5131
7. Sozzi G, Alder H, Tornielli S, Corietto V, Baffa R, Veronese ML, Negrini M, Pilotti S, Pierotti MA, Kuebner K, Croce CM: Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 1996, 56:2473-2474
8. Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW, Croce CM, Huebner K: Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′,5″-P,P-triphosphate hydrolase. Biochemistry 1996, 35:11529-11535
9. Wienecke R. Maize JC, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, Resau JH, deGunzburg J, Yeung RS, DeClue JE: Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 1996, 13:913-923
10. Yeung RS, Katsetos CD, Klein-Szanto A: Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 1997, 151:1477-1486
11. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J, Cooper CS: The t(X;1)(p11.2; q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 1996, 5:1333-1338
12. van den Berg A, Buys CH: Involvement of multiple Ioci on chromosome 3 in renal cell cancer development. Genes Chromosomes Cancer 1997, 19:59-76
13. Kovacs G, Kung HF: Nonhomologous chromatid exchange in hereditary and sporadic renal cell carcinomas. Proc Natl Acad Sci USA 1991, 88:194-198
14. th Annual Meeting of the American Association for Cancer Research, San Diego. 1997
15. Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS: The tuberous sclerosis-2 gene product, tuberin, functions as a Rab5GAP in modulating endocytosis. J Biol Chem 1997, 272:6097-6100